FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1957758434> ?p ?o ?g. }

• W1957758434 abstract "In patients with acute ischaemic stroke, platelets become activated. Antiplatelet therapy might reduce the volume of brain damaged by ischaemia and reduce the risk of early recurrent ischaemic stroke. This might reduce the risk of early death and improve long-term outcome in survivors. However, antiplatelet therapy might also increase the risk of fatal or disabling intracranial haemorrhage.To assess the efficacy and safety of antiplatelet therapy in acute ischaemic stroke.We searched the Cochrane Stroke Group Trials Register (last searched June 2007), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2007), MEDLINE (June 1998 to May 2007), and EMBASE (June 1998 to May 2007). In 1998, for a previous version of this review, we searched the register of the Antiplatelet Trialists' Collaboration, MedStrategy and contacted relevant drug companies.Randomised trials comparing antiplatelet therapy (started within 14 days of the stroke) with control in patients with definite or presumed ischaemic stroke.Two review authors independently applied the inclusion criteria and assessed trial quality, and for the included trials, extracted and cross-checked the data.Twelve trials involving 43,041 participants were included. Two trials testing aspirin 160 mg to 300 mg once daily started within 48 hours of onset contributed 94% of the data. The maximum follow up was six months. With treatment, there was a significant decrease in death or dependency at the end of follow up (odds ratio 0.95, 95% confidence interval 0.91 to 0.99). For every 1000 patients treated with aspirin, 13 patients will avoid death or dependency (number needed to treat to benefit: 79). Antiplatelet therapy was associated with a small but definite excess of symptomatic intracranial haemorrhages, but this was more than offset by the reduction of recurrent ischaemic strokes and pulmonary embolus.Antiplatelet therapy with aspirin 160 mg to 300 mg daily, given orally (or by nasogastric tube or per rectum in patients who cannot swallow), and started within 48 hours of onset of presumed ischaemic stroke reduces the risk of early recurrent ischaemic stroke without a major risk of early haemorrhagic complications and improves long-term outcome." @default.
• W1957758434 created "2016-06-24" @default.
• W1957758434 creator A5019382485 @default.
• W1957758434 creator A5029838434 @default.
• W1957758434 creator A5069714256 @default.
• W1957758434 creator A5083154337 @default.
• W1957758434 date "2008-07-16" @default.
• W1957758434 modified "2023-09-30" @default.
• W1957758434 title "Antiplatelet therapy for acute ischaemic stroke" @default.
• W1957758434 cites W1498265361 @default.
• W1957758434 cites W1512461647 @default.
• W1957758434 cites W1532205670 @default.
• W1957758434 cites W1929039485 @default.
• W1957758434 cites W1970934606 @default.
• W1957758434 cites W1971442835 @default.
• W1957758434 cites W1972083038 @default.
• W1957758434 cites W1972215351 @default.
• W1957758434 cites W1982660761 @default.
• W1957758434 cites W2001337872 @default.
• W1957758434 cites W2012936624 @default.
• W1957758434 cites W2023495966 @default.
• W1957758434 cites W2024352468 @default.
• W1957758434 cites W2026458612 @default.
• W1957758434 cites W2038757076 @default.
• W1957758434 cites W2046166586 @default.
• W1957758434 cites W2065366606 @default.
• W1957758434 cites W2075862091 @default.
• W1957758434 cites W2078944165 @default.
• W1957758434 cites W2089782611 @default.
• W1957758434 cites W2094751695 @default.
• W1957758434 cites W2104736983 @default.
• W1957758434 cites W2108361166 @default.
• W1957758434 cites W2126372563 @default.
• W1957758434 cites W2129568225 @default.
• W1957758434 cites W2132247347 @default.
• W1957758434 cites W2142848477 @default.
• W1957758434 cites W2170958741 @default.
• W1957758434 cites W2198317276 @default.
• W1957758434 cites W2292308933 @default.
• W1957758434 cites W2317947810 @default.
• W1957758434 cites W2331216347 @default.
• W1957758434 cites W2478734695 @default.
• W1957758434 cites W2495479321 @default.
• W1957758434 cites W2594075545 @default.
• W1957758434 cites W2767080640 @default.
• W1957758434 cites W3146270511 @default.
• W1957758434 cites W4211005142 @default.
• W1957758434 cites W4239471829 @default.
• W1957758434 cites W4245197683 @default.
• W1957758434 cites W4245428103 @default.
• W1957758434 cites W4249374822 @default.
• W1957758434 cites W4251622087 @default.
• W1957758434 doi "https://doi.org/10.1002/14651858.cd000029.pub2" @default.
• W1957758434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18646056" @default.
• W1957758434 hasPublicationYear "2008" @default.
• W1957758434 type Work @default.
• W1957758434 sameAs 1957758434 @default.
• W1957758434 citedByCount "117" @default.
• W1957758434 countsByYear W19577584342012 @default.
• W1957758434 countsByYear W19577584342013 @default.
• W1957758434 countsByYear W19577584342014 @default.
• W1957758434 countsByYear W19577584342015 @default.
• W1957758434 countsByYear W19577584342016 @default.
• W1957758434 countsByYear W19577584342017 @default.
• W1957758434 countsByYear W19577584342018 @default.
• W1957758434 countsByYear W19577584342020 @default.
• W1957758434 countsByYear W19577584342021 @default.
• W1957758434 countsByYear W19577584342022 @default.
• W1957758434 countsByYear W19577584342023 @default.
• W1957758434 crossrefType "reference-entry" @default.
• W1957758434 hasAuthorship W1957758434A5019382485 @default.
• W1957758434 hasAuthorship W1957758434A5029838434 @default.
• W1957758434 hasAuthorship W1957758434A5069714256 @default.
• W1957758434 hasAuthorship W1957758434A5083154337 @default.
• W1957758434 hasConcept C126322002 @default.
• W1957758434 hasConcept C127413603 @default.
• W1957758434 hasConcept C156957248 @default.
• W1957758434 hasConcept C168563851 @default.
• W1957758434 hasConcept C1862650 @default.
• W1957758434 hasConcept C2776478404 @default.
• W1957758434 hasConcept C2777265216 @default.
• W1957758434 hasConcept C2777628954 @default.
• W1957758434 hasConcept C2777849778 @default.
• W1957758434 hasConcept C2780645631 @default.
• W1957758434 hasConcept C2909112448 @default.
• W1957758434 hasConcept C44249647 @default.
• W1957758434 hasConcept C535046627 @default.
• W1957758434 hasConcept C71924100 @default.
• W1957758434 hasConcept C78519656 @default.
• W1957758434 hasConcept C82789193 @default.
• W1957758434 hasConcept C95190672 @default.
• W1957758434 hasConceptScore W1957758434C126322002 @default.
• W1957758434 hasConceptScore W1957758434C127413603 @default.
• W1957758434 hasConceptScore W1957758434C156957248 @default.
• W1957758434 hasConceptScore W1957758434C168563851 @default.
• W1957758434 hasConceptScore W1957758434C1862650 @default.
• W1957758434 hasConceptScore W1957758434C2776478404 @default.
• W1957758434 hasConceptScore W1957758434C2777265216 @default.
• W1957758434 hasConceptScore W1957758434C2777628954 @default.
• W1957758434 hasConceptScore W1957758434C2777849778 @default.

• next